ArticleEClinicalMedicine2024

Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial.

Hongzhou Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.